Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization

Recruiting now

Conditions studied: Coronary Bypass Graft Occlusion

In brief

This study is to evaluate the correlation between hs-cTn level as cardiac biomarker for ischemia and early graft occlusion as assessed by CCT in patients undergoing coronary bypass surgery.

Key facts

Study ID

NCT04595630

Run by

University Hospital, Basel, Switzerland

People needed

480

Starts

2021-07-01

Expected to finish

2029-12-01

Last updated by the study team

2025-02-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with isolated coronary bypass surgery

You may not qualify if…

• Patients withholding or lacking informed consent
• Patients requiring a concomitant procedure
• Exclusion criteria concerning the CCT scan
• Patients with known allergy to iodine-containing contrast agents
• Renal function impairment (serum creatinine >140 mmol/l; estimated glomerular filtration rate (GFR) <30 ml/min/1.73 m2).
• Pregnancy
• Unstable clinical state or severe heart failure
• Patients with registered MI and registered bypass occlusion in coronary angiogram
• Patients that didn't undergo a CCT prior to discharge

Where it is running

• Department for Cardiac Surgery, University Hospital Basel — Basel, Switzerland (enrolling)
• University Hospital Centre Zagreb — Zagreb, Croatia
• Wroclaw Medical University — Wroclaw, Borowska, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.